https://www.nature.com/articles/d41586-023-02171-x
0
0
6/28/23 at 5:30pm
Organization
Nature.com
40 words
0
Comments
The candidate is moving to long-awaited phase III trials — if successful, it would be the first new jab against the disease in more than 100 years.
You are the first to view
Create an account
or login to join the discussion